SCHEMBL21102201

SCHEMBL21102201

CC(C)Cc1cc(C(F)(F)F)ccc1CC(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.40
▸ HTR2B P41595 2/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ PDE2A O00408 3/20 0.37
▸ SLC6A4 P31645 3/20 0.36
▸ SLC6A2 P23975 2/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ IDO1 P14902 2/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ PTGER1 P34995 1/20 0.35
▸ PTGER3 P43115 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3101204 0.83 HTR2A (0.44) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL23841644 0.80 DAO (0.44) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL12844885 0.79 PDE3B (0.45) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL29453102 0.79 IDO1 (0.53) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL12304037 0.79 IDO1 (0.53) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL8225527 0.79 IDO1 (0.53) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL20651130 0.79 HTR2A (0.42) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL5907020 0.79 HTR2A (0.42) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL17069243 0.77 SLC6A4 (0.52) HTR2AHTR2BHTR2CPDE2ASLC6A4
SCHEMBL18682189 0.77 PDE2A (0.53) HTR2AHTR2BHTR2CPDE2ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 — — WO disclosed
Send feedback